LINQ II Insertable Cardiac Monitor
Overview
The Medtronic LINQ II™ Insertable Cardiac Monitor (ICM) is a state-of-the-art, miniaturized device designed for long-term, continuous heart monitoring. Approximately one-third the size of a AAA battery, it is subcutaneously implanted in a minimally invasive procedure, offering discreet and persistent monitoring for up to 4.5 years. This device is indicated for adult patients and pediatric patients aged two years and older who are at increased risk of cardiac arrhythmias or experience transient symptoms such as dizziness, palpitations, syncope, and chest pain that may suggest an arrhythmia.
A core innovation of the LINQ II ICM is its integration with AccuRhythm™ AI algorithms. This groundbreaking artificial intelligence platform applies deep learning to ECG data flowing into the Medtronic CareLink™ network, significantly enhancing the accuracy of atrial fibrillation (AF) and Pause detection. The cloud-based AI system is proven to reduce false alerts by over 91% while preserving nearly all true alerts, thereby streamlining clinician workflows and allowing more time for critical patient care.
The LINQ II system offers flexible and convenient remote patient management. Patients can transmit device data automatically via the MyCareLink Heart™ mobile app (compatible with both iOS and Android smartphones/tablets) or the MyCareLink Relay™ home communicator. This remote connectivity, including the first-ever remote programming capability for an ICM, allows clinicians to optimize device settings post-insertion without the need for in-office visits, reducing patient burden and improving compliance. The device is also MRI-compatible (at 1.5 and 3.0T) and features end-to-end encryption to ensure the security and privacy of patient data.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AccuRhythmu2122 AI algorithms for enhanced accuracy
- Remote programming capability
- Up to 4.5 years of continuous monitoring
- MRI compatibility (1.5 and 3.0T)
- MyCareLink Heartu2122 mobile app for data transmission
- MyCareLink Relayu2122 home communicator option
- Innovative PVC detection algorithm
- Pediatric indication (ages 2+)
- End-to-end data encryption
- Minimally invasive implantation
Use Cases
- Long-term monitoring for cardiac arrhythmias
- Diagnosing unexplained syncope (fainting)
- Investigating palpitations and chest pain
- Managing atrial fibrillation (AFib)
- Detecting AFib after cryptogenic stroke
- Reducing false alerts in cardiac monitoring
What Physicians Need to Know
The LINQ II ICM offers continuous, long-term monitoring for up to 4.5 years, providing extensive data for diagnosing infrequent arrhythmias and managing chronic cardiac conditions. The AccuRhythm™ AI algorithms significantly reduce false alerts, minimizing review burden and allowing more focus on clinically relevant events. Remote programming capabilities and seamless integration with the MyCareLink Heart™ app and CareLink™ Network can reduce the need for in-office visits and streamline workflows. Consider the LINQ II ICM for patients with unexplained syncope, palpitations, chest pain, or cryptogenic stroke, as well as for long-term monitoring in heart failure patients to detect actionable arrhythmias. The device is MRI-conditional, offering flexibility for future imaging needs.
The LINQ II ICM integrates with the MyCareLink Heart™ mobile app for automatic data transfer via Bluetooth® to the Medtronic CareLink™ Network. This allows for remote monitoring and management by clinicians. The system also supports a MyCareLink Relay™ home communicator for bedside use if a smartphone is not compatible or preferred.
Details
| Category | Cardiology AI, Clinical Decision Support & Reference |
| Pricing | Unknown |
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. |
| Mobile App | MyCareLink Heart™ mobile app (for patients) and Reveal LINQ™ Mobile Manager app (for healthcare professionals) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2023-12-06 | K233562 510(k) | LINQ II Insertable Cardiac Monitor |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate LINQ II Insertable Cardiac Monitor
Videos
Product demos, reviews, and walkthroughs for LINQ II Insertable Cardiac Monitor.
LINQ IIu2122 Insertable Cardiac Monitoring (ICM) System
Medtronic Cardiac and Vascular
Getting Started with the MyCareLink Heartu2122 Mobile App for LINQ IIu2122 Insertable Cardiac Monitor
Medtronic Cardiac and Vascular
Meet LINQ IIu2122 Insertable Cardiac Monitoring System
Medtronic Cardiac and Vascular
Introduction to the LINQ IIu2122 ICM System
Medtronic Cardiac and Vascular
Living with the LINQ IIu2122 ICM
Medtronic Cardiac and Vascular
Frequently Asked Questions
Compare LINQ II Insertable Cardiac Monitor
VS
VS
VS
VS








